CTSO

6.37

0.63% 0.04

Dopo l'orario di chiusura: 6.43 0.06 +0.94%

Cytosorbents Corp (CTSO)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché CTSO Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$6.33

Aprire:

$6.37

Volume 24 ore:

14,387

Relative Volume:

1.15

Capitalizzazione di mercato:

$20.07M

Reddito:

$37.20M

Utile/perdita netta:

$-11.85M

Rapporto P/E:

-33.39

EPS:

-0.1908

Flusso di cassa netto:

$-10.59M

1 W Prestazione:

-9.00%

1M Prestazione:

-12.02%

6M Prestazione:

-59.27%

1 anno Prestazione:

-66.31%

Intervallo 1D:

$6.25

$6.74

Intervallo di 1 settimana:

$6.11

$7.44

Portata 52W:

$6.005

$20.40

Cytosorbents Corp Stock (CTSO) Company Profile

Nome

Cytosorbents Corp

Settore

Healthcare (1069)

Industria

Medical Devices (140)

Telefono

973-329-8885

Indirizzo

305 COLLEGE ROAD EAST, PRINCETON, NJ

Dipendente

129

Cinguettio

@CytoSorbents

Prossima data di guadagno

2026-08-06

Ultimi documenti SEC

CTSO's Discussions on Twitter

Compare CTSO vs ABT, MDT, SYK, BSX, EW

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CTSO Cytosorbents Corp	6.37	19.95M	37.20M	-11.85M	-10.59M	-0.1908
ABT Abbott Laboratories	103.36	182.09B	46.59B	5.41B	7.38B	3.0938
MDT Medtronic Plc	91.62	117.54B	36.36B	4.84B	5.43B	3.7261
SYK Stryker Corp	270.01	105.63B	25.27B	3.34B	4.57B	8.6334
BSX Boston Scientific Corp	43.10	65.16B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	86.77	49.67B	6.30B	1.07B	1.09B	1.8406

Cytosorbents Corp Stock (CTSO) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-09-07	Iniziato	B. Riley Securities	Buy
2021-10-14	Ripresa	B. Riley Securities	Buy
2020-09-17	Iniziato	Jefferies	Buy
2020-09-01	Iniziato	SVB Leerink	Outperform
2017-08-08	Reiterato	Maxim Group	Buy
2016-10-26	Iniziato	Aegis Capital	Buy
2016-05-24	Iniziato	Maxim Group	Buy
2015-10-29	Aggiornamento	WBB Securities	Speculative Buy → Buy
2015-05-12	Reiterato	MLV & Co	Buy
2015-04-01	Reiterato	MLV & Co	Buy
2015-03-05	Iniziato	MLV & Co	Buy
2015-02-25	Iniziato	WBB Securities	Speculative Buy
2015-01-27	Reiterato	H.C. Wainwright	Buy

Mostra tutto

Cytosorbents Corp Borsa (CTSO) Ultime notizie

07:20 AM

CytoSorbents to present at H.C. Wainwright conf... - Pluang

07:20 AM

07:00 AM

CytoSorbents to Present at the H.C. Wainwright 28th Annual Global Investment Conference - PR Newswire

07:00 AM

Sep 09, 2026

Cytosorbents CEO Phillip Chan buys 200,000 shares for $70,000 By Investing.com - Investing.com South Africa

Sep 09, 2026

Cytosorbents CEO Phillip Chan buys 200,000 shares for $70,000 - Investing.com

Sep 09, 2026

CytoSorbents Corp (STU:HQE) Stock Earnings Transcripts - GuruFocus

Sep 09, 2026

Sep 08, 2026

CytoSorbents to Report Second Quarter 2026 Financial Results and Recent Business Highlights - easternprogress.com

Sep 08, 2026

Sep 04, 2026

CytoSorbents to present at Moody Capital Soluti... - Pluang

Sep 04, 2026

CytoSorbents to Present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference - The Globe and Mail

Sep 04, 2026

Sep 03, 2026

CytoSorbents Plans 1-for-20 Reverse Stock Split to Maintain Nasdaq Listing - citybiz

Sep 03, 2026

CytoSorbents Announces New Real-World Data Demonstrating Significant Reduction in Severe Bleeding Using CytoSorb in CABG Patients on Ticagrelor and Updates Recent DrugSorb-ATR FDA Pre-Submission Meetings - Yahoo Finance

Sep 02, 2026

Aug 24, 2026

Cytosorbents Earnings Call Balances Progress and Risk - TipRanks

Aug 24, 2026

Aug 18, 2026

Cytosorbents (CTSO) Financial Update: EPS Comes in Below Forecast; Market Follow-Through: Shares Finish 4.56% LowerEarnings Season Outlook - vinanet.vn

Aug 18, 2026

Aug 14, 2026

CytoSorbents (CTSO) wins approval for reverse split and director slate at 2026 meeting - Stock Titan

Aug 14, 2026

Aug 13, 2026

Cytosorbents (CTSO) Q2 2026 Earnings Call Transcript - The Globe and Mail

Aug 13, 2026

Cytosorbents Corp. R (HQE1.DU) Q1 FY2026 earnings call transcript - Yahoo Finance

Aug 13, 2026

Aug 10, 2026